Lars Farde

Research.com Recognitions

• 2026 - Research.com Neuroscience in Sweden Leader Award
• 2025 - Research.com Neuroscience in Sweden Leader Award
• 2023 - Research.com Medicine in Sweden Leader Award
• 2022 - Research.com Neuroscience in Sweden Leader Award

Overview

Best Publications

• Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects

  Lars Farde;Anna-Lena Nordström;Frits-Axel Wiesel;Stefan Pauli

  2084
  Citations

• Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET

  Lars Farde;Håkan Hall;Erling Ehrin;Göran Sedvall

  1021
  Citations

• The correlative triad among aging, dopamine, and cognition: current status and future prospects.

  Lars Bäckman;Lars Nyberg;Ulman Lindenberger;Shu-Chen Li

  942
  Citations

• Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs

  Lars Farde;Fritz-Axel Wiesel;Christer Halldin;Göran Sedvall

  868
  Citations

• Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

  E G Jönsson;M M Nöthen;F Grünhage;L Farde

  836
  Citations

• Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training

  F McNab;A Varrone;L Farde;A Jucaite

  757
  Citations

• Age-related cognitive deficits mediated by changes in the striatal dopamine system.

  Lars Bäckman;Nathalie Ginovart;Roger A. Dixon;Tarja-Brita Robins Wahlin

  674
  Citations

• D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

  Lars Farde;Frits-Axel Wiesel;Sharon Stone-Elander;Christer Halldin

  664
  Citations

• Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

  Anna-Lena Nordström;Lars Farde;Frits-Axel Wiesel;Kaj Forslund

  659
  Citations

• Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.

  L. Farde;L. Eriksson;G. Blomquist;C. Halldin

  523
  Citations

• Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.

  Håkan Hall;Göran Sedvall;Olle Magnusson;Jutta Kopp

  506
  Citations

• Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.

  Valtteri Kaasinen;Harry Vilkman;Jarmo Hietala;Kjell Någren

  461
  Citations

• D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.

  A L Nordström;L Farde;S Nyberg;P Karlsson

  423
  Citations

• D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics.

  L Farde;F A Wiesel;A L Nordström;G Sedvall

  415
  Citations

• The serotonin system and spiritual experiences.

  Jacqueline Borg;Bengt Andrée;Henrik Soderstrom;Lars Farde

  401
  Citations

• Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography.

  Lars Farde;Erling Ehrin;Lars Eriksson;Torgny Greitz

  384
  Citations

• No D2 receptor increase in PET study of schizophrenia.

  Lars Farde;Frits-Axel Wiesel;HÅkan Hall;Christer Halldin

  372
  Citations

• PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

  L Farde;C Halldin;S Stone-Elander;G Sedvall

  364
  Citations

• Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen.

  Olle Lindvall;Erik‐Olof Backlund;Lars Farde;Göran Sedvall

  350
  Citations

• The role of the striatal dopamine transporter in cognitive aging

  Nina Erixon-Lindroth;Lars Farde;Tarja-Brita Robins Wahlin;Judit Sovago

  339
  Citations

• The International Journal of Neuropsychopharmacology.

  Unknown

  160
  Citations